$71.90▾ 0.14%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$2.69cash per $1 profit
Strong
It turns every reported profit-dollar into real cash, and then some.
Valuation
66th pctvs its own history
Fair
Its valuation is around the middle of its own recent range.
Revenue growth
-1.5%year over year
Weak
Revenue is contracting year over year.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 55% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Bio-Techne Corp turns 269¢ of every reported profit-dollar into real cash. Revenue is contracting year over year. Its valuation is around the middle of its own recent range.
Key numbers
Valuation
EPS (TTM)$0.69
TTM (trailing 12 months, through fiscal Q3 FY2026)
Profitability
Net margin9.0%
TTM (trailing 12 months, through fiscal Q3 FY2026)
Size
Revenue (TTM)$1.21B
TTM (trailing 12 months, through fiscal Q3 FY2026)
Recent news
Signals and key numbers are from the fiscal Q3 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.